Navigation Links
Easton honored with inaugural AACR Outstanding Investigator Award in Breast Cancer Research
Date:12/11/2008

SAN ANTONIO Douglas Easton, Ph.D., whose international studies in breast cancer explained the genetic patterns and causes of the BRCA1 and BRCA2 gene mutations which indicate a person's risk for breast cancer, has been selected to receive the inaugural American Association for Cancer Research (AACR) Outstanding Investigator Award in Breast Cancer Research.

This award, funded by Susan G. Komen for the Cure, recognizes an investigator whose novel and significant work has had or may have a far-reaching impact on the causes, detection, diagnosis, treatment or prevention of breast cancer.

Easton, professor of genetic epidemiology and director of the Cancer Research UK Genetic Epidemiology Unit in the Department of Public Health and Primary Care at the University of Cambridge, has been selected for his national and international studies of the genetic causes and patterns of breast cancer. As a result of his work, Easton established the Breast Cancer Linage Consortium, which provided the first estimates of breast and ovarian cancer risk in BRCA1 mutation carriers and developed a risk model that is used daily in clinics worldwide.

Most recently, Easton assisted in identifying five breast cancer genes located in specific areas on the chromosome which impact breast cancer susceptibility, none of which had previously been associated with breast cancer: FGFR2, TNRC9, MAP3K1, LSP1 and a locus on 8q. Subsequently, he demonstrated how variations in these loci are associated with increased risk of breast cancer in BRCA mutation carriers. These observations may become important in counseling women who carry the BRCA mutation, and will be important for risk stratification in the general population.

Easton received Bachelor of Arts and Master of Arts degrees in mathematics from the University of Cambridge. He earned a doctorate in Genetic Epidemiology from the University of London. In 1980 Dr. Easton was recruited to a research fellow position at the Institute of Cancer Research. In 1995, Dr. Easton moved to Cambridge to become director of the Cancer Research Genetic Epidemiology Unit.

Easton will give an award lecture entitled, "Recent Developments in Genetic Susceptibility to Breast Cancer," on Thursday, December 11, 2008, at 11:30 a.m. CST, during the 31st Annual CTRC-AACR San Antonio Breast Cancer Symposium, in San Antonio, Texas.


'/>"/>

Contact: Megan Davies
megan.davies@aacr.org
267-646-0612
American Association for Cancer Research
Source:Eurekalert

Related biology news :

1. Easton, PA Police Officers Armed With BIO-key(R) Mobile Data Solution Access Information Anytime, Anywhere
2. UTMB researchers to be honored at Oscars of invention
3. ESA honored at White House ceremony
4. UT Southwestern scientist honored among best in Texas research
5. Rices West honored as one of Texas best researchers
6. Jeremy Jackson honored by Harvard Museum of Natural History
7. NJIT Provost Priscilla P. Nelson honored at National Academy of Engineering
8. Yales Anastas honored for leadership in founding of green chemistry
9. Springer editor honored with top environmental prize
10. Sen. Byron Dorgan to be honored
11. Leader of Human Genome Project honored with the Inamori Ethics Prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... WASHINGTON , Feb. 27, 2017   Strategic ... fund, today announced it has led a $3.5 million investment ... collaboration platform. Strategic Cyber Ventures is DC based and ... and Hank Thomas . Ron Gula , ... Tech Ventures, also participated in this series A round ...
(Date:2/24/2017)... , Feb. 24, 2017  EyeLock LLC, a leader of ... elite iris biometric solution on the latest Qualcomm® ... at Mobile World Congress 2017 (February 27 ... in Hall 3, Stand 3E10. ... Haven™ security platform—a combination of hardware, software ...
(Date:2/21/2017)... ARMONK, N.Y. and PORTLAND, Ore. ... IBM ) and the Avamere Family of Companies (Avamere ... Care) today announced a six-month research study that will ... caregivers improve eldercare at senior living and health centers. ... facilities, Avamere hopes to gain insights into physical and ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ... March 23, 2017 , ... AxioMed president, Jake Lubinski, describes ... characteristics when deformed, which is identical to how the human discs work to ... and return to its natural state along a hysteresis curve, exactly like a ...
(Date:3/23/2017)... 23, 2017  SeraCare Life Sciences, Inc., a ... vitro diagnostics manufacturers and clinical laboratories, is ... multiplexed Inherited Cancer reference material ... next-generation sequencing (NGS). The Seraseq™ Inherited Cancer DNA ... from industry experts to validate the ability ...
(Date:3/23/2017)... March 23, 2017 Kineta, Inc., a ... novel therapies in immuno-oncology, today announced the discovery ... molecule compounds that activate interferon response factor 3 ... demonstrate immune-mediated tumor regression in a murine colon ... who demonstrated complete tumor regression to initial drug ...
(Date:3/23/2017)... , March 23, 2017 In ... four equities in the Biotech industry: Sangamo Therapeutics Inc. ... Inc. (NYSE MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... , 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from ... their free report at: ...
Breaking Biology Technology: